The Moderating Role of Health Status on the Association Between Depressive Symptoms and Cannabis Vaping
Author:
Blair Alexandra,Clawson Ashley,Keirns Natalie,Mullins Larry,Chaney John
Abstract
Objective: Cannabis vaping is increasing among college students. There is little information on risk factors for vaping cannabis. Consistent with the self-medication hypothesis, experiencing depressive symptoms and having a chronic medical condition (CMC) are associated with cannabis use among young adults. Individuals who experience both risk factors may be at higher risk for cannabis vaping. This study examined cross-sectional associations between depressive symptoms, CMC status, and cannabis vaping, and identified the moderating role of CMC status on depressive symptoms and cannabis vaping. Method: College students (N = 3,742) self-reported on depressive symptoms, CMC status, and lifetime and current cannabis vaping (i.e., cannabis vaporizers; electronic nicotine devices to use cannabis). Data were collected Fall 2017 until Spring 2021. The sample was predominantly female (70.9%) and White (75.4%). Regression analyses were used. Results: Greater depressive symptoms were related to increased likelihood of cannabis vaping across outcomes. Having a CMC was related to lifetime history of cannabis vaporizing. CMC status moderated the associations between depressive symptoms and lifetime cannabis vaporizing. Depressive symptoms were only a risk factor for cannabis vaporizing among college students without a CMC, not those with a CMC. Conclusions: Interventions that teach adaptive ways of coping with depressive symptoms and the potential demands of managing a CMC in college are needed. Comprehensive programs for college students, with and without CMCs, are needed to support those with comorbid depression and cannabis vaping use.
Funder
National Cancer Institute National Institute of Mental Health
Publisher
Research Society on Marijuana
Reference75 articles.
1. American College Health. (2018). American College Health Association national college health assessment II: Spring 2018 reference group executive summary. Hanover, MD: American College Health Association. https://www.acha.org/documents/ncha/NCHA-II_Spring_2018_Reference_Group_Executive_Summary.pdf 2. Boakye, E., Obisesan, O. H., Uddin, S. M. I., El-Shahawy, O., Dzaye, O., Osei, A. D., Benjamin, E. J., Stokes, A. C., Robertson, R. M., Bhatnagar, A., & Blaha, M. J. (2021). Cannabis vaping among adults in the United States: Prevalence, trends, and association with high-risk behaviors and adverse respiratory conditions. Preventive Medicine, 153. https://doi.org/10.1016/j.ypmed.2021.106800 3. Bolanis, D., Orri, M., Castellanos-Ryan, N., Renaud, J., Montreuil, T., Boivin, M., Vitaro, F., Tremblay, R. E., Turecki, G., Côté, S. M., Séguin, J. R., & Geoffroy, M. C. (2020). Cannabis use, depression and suicidal ideation in adolescence: direction of associations in a population based cohort. Journal of Affective Disorders, 274(May), 1076-1083. https://doi.org/10.1016/j.jad.2020.05.136 4. Borodovsky, J. T., Lee, D. C., Crosier, B. S., Gabrielli, J. L., Sargent, J. D., & Budney, A. J. (2017). U.S. cannabis legalization and use of vaping and edible products among youth. Drug and Alcohol Dependence, 177, 299-306. https://doi.org/10.1016/j.drugalcdep.2017.02.017 5. Bottorff, J. L., Johnson, J. L., Moffat, B. M., & Mulvogue, T. (2009). Relief-oriented use of marijuana by teens. Substance Abuse: Treatment, Prevention, and Policy, 4, 0-29. https://doi.org/10.1186/1747-597X-4-7
|
|